Literature DB >> 32078586

Muscle-derived interleukin 6 increases exercise capacity by signaling in osteoblasts.

Subrata Chowdhury1, Logan Schulz1, Biagio Palmisano1, Parminder Singh2, Julian M Berger1, Vijay K Yadav1,2, Paula Mera1,3,4,5, Helga Ellingsgaard6,7, Juan Hidalgo8, Jens Brüning9, Gerard Karsenty1.   

Abstract

Given the numerous health benefits of exercise, understanding how exercise capacity is regulated is a question of paramount importance. Circulating interleukin 6 (IL-6) levels surge during exercise and IL-6 favors exercise capacity. However, neither the cellular origin of circulating IL-6 during exercise nor the means by which this cytokine enhances exercise capacity has been formally established yet. Here we show through genetic means that the majority of circulating IL-6 detectable during exercise originates from muscle and that to increase exercise capacity, IL-6 must signal in osteoblasts to favor osteoclast differentiation and the release of bioactive osteocalcin in the general circulation. This explains why mice lacking the IL-6 receptor only in osteoblasts exhibit a deficit in exercise capacity of similar severity to the one seen in mice lacking muscle-derived IL-6 (mIL-6), and why this deficit is correctable by osteocalcin but not by IL-6. Furthermore, in agreement with the notion that IL-6 acts through osteocalcin, we demonstrate that mIL-6 promotes nutrient uptake and catabolism into myofibers during exercise in an osteocalcin-dependent manner. Finally, we show that the crosstalk between osteocalcin and IL-6 is conserved between rodents and humans. This study provides evidence that a muscle-bone-muscle endocrine axis is necessary to increase muscle function during exercise in rodents and humans.

Entities:  

Keywords:  Bone Biology; Osteoclast/osteoblast biology; Skeletal muscle

Mesh:

Substances:

Year:  2020        PMID: 32078586      PMCID: PMC7260002          DOI: 10.1172/JCI133572

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

Review 1.  Muscles, exercise and obesity: skeletal muscle as a secretory organ.

Authors:  Bente K Pedersen; Mark A Febbraio
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

2.  Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes.

Authors:  Rachel J Perry; João-Paulo G Camporez; Romy Kursawe; Paul M Titchenell; Dongyan Zhang; Curtis J Perry; Michael J Jurczak; Abulizi Abudukadier; Myoung Sook Han; Xian-Man Zhang; Hai-Bin Ruan; Xiaoyong Yang; Sonia Caprio; Susan M Kaech; Hei Sook Sul; Morris J Birnbaum; Roger J Davis; Gary W Cline; Kitt Falk Petersen; Gerald I Shulman
Journal:  Cell       Date:  2015-02-05       Impact factor: 41.582

3.  Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action.

Authors:  F Thomas Wunderlich; Peter Ströhle; A Christine Könner; Sabine Gruber; Sulay Tovar; Hella S Brönneke; Lisa Juntti-Berggren; Luo-Sheng Li; Nico van Rooijen; Claude Libert; Per-Olof Berggren; Jens C Brüning
Journal:  Cell Metab       Date:  2010-09-08       Impact factor: 27.287

Review 4.  IL-6/IL-6 receptor system and its role in physiological and pathological conditions.

Authors:  Masahiko Mihara; Misato Hashizume; Hiroto Yoshida; Miho Suzuki; Masashi Shiina
Journal:  Clin Sci (Lond)       Date:  2012-02       Impact factor: 6.124

5.  Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum.

Authors:  Vijay K Yadav; Je-Hwang Ryu; Nina Suda; Kenji F Tanaka; Jay A Gingrich; Günther Schütz; Francis H Glorieux; Cherie Y Chiang; Jeffrey D Zajac; Karl L Insogna; J John Mann; Rene Hen; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2008-11-28       Impact factor: 41.582

6.  Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction.

Authors:  Mark A Febbraio; Natalie Hiscock; Massimo Sacchetti; Christian P Fischer; Bente K Pedersen
Journal:  Diabetes       Date:  2004-07       Impact factor: 9.461

7.  Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.

Authors:  T Tamura; N Udagawa; N Takahashi; C Miyaura; S Tanaka; Y Yamada; Y Koishihara; Y Ohsugi; K Kumaki; T Taga
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

8.  Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization.

Authors:  Mei Zhang; Shouhong Xuan; Mary L Bouxsein; Dietrich von Stechow; Nagako Akeno; Marie Claude Faugere; Hartmut Malluche; Guisheng Zhao; Clifford J Rosen; Argiris Efstratiadis; Thomas L Clemens
Journal:  J Biol Chem       Date:  2002-09-04       Impact factor: 5.157

9.  Mediation of the Acute Stress Response by the Skeleton.

Authors:  Julian Meyer Berger; Parminder Singh; Lori Khrimian; Donald A Morgan; Subrata Chowdhury; Emilio Arteaga-Solis; Tamas L Horvath; Ana I Domingos; Anna L Marsland; Vijay Kumar Yadav; Kamal Rahmouni; Xiao-Bing Gao; Gerard Karsenty
Journal:  Cell Metab       Date:  2019-09-12       Impact factor: 27.287

10.  Correction: Inducible Cre transgenic mouse strain for skeletal muscle-specific gene targeting.

Authors:  John J McCarthy; Ratchakrit Srikuea; Tyler J Kirby; Charlotte A Peterson; Karyn A Esser
Journal:  Skelet Muscle       Date:  2012-10-30       Impact factor: 4.912

View more
  24 in total

Review 1.  Muscle-Bone Crosstalk in Chronic Kidney Disease: The Potential Modulatory Effects of Exercise.

Authors:  Diogo V Leal; Aníbal Ferreira; Emma L Watson; Kenneth R Wilund; João L Viana
Journal:  Calcif Tissue Int       Date:  2021-01-02       Impact factor: 4.333

Review 2.  Interleukin 6 as an energy allocator in muscle tissue.

Authors:  Timothy M Kistner; Bente K Pedersen; Daniel E Lieberman
Journal:  Nat Metab       Date:  2022-02-24

3.  Interleukin-6 May Not Affect Bone Resorption Marker CTX or Bone Formation Marker P1NP in Humans.

Authors:  Louise L Lehrskov; Sasha Kjeldsen; Mark P Lyngbæk; Regitse Højgaard Chirstensen; Anne-Sophie Wedell-Neergaard; Line Søderlund; Niklas Rye Jørgensen; Rikke Krogh-Madsen; Nicolai J Wewer Albrechtsen; Helga Ellingsgaard
Journal:  J Endocr Soc       Date:  2020-07-07

Review 4.  Bone-Muscle Mutual Interactions.

Authors:  Nuria Lara-Castillo; Mark L Johnson
Journal:  Curr Osteoporos Rep       Date:  2020-08       Impact factor: 5.096

Review 5.  Neurogenic Obesity and Skeletal Pathology in Spinal Cord Injury.

Authors:  David W McMillan; Mark S Nash; David R Gater; Rodrigo J Valderrábano
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

6.  Physical Activity Regulates TNFα and IL-6 Expression to Counteract Inflammation in Cystic Fibrosis Patients.

Authors:  Ersilia Nigro; Rita Polito; Ausilia Elce; Giuseppe Signoriello; Paola Iacotucci; Vincenzo Carnovale; Monica Gelzo; Federica Zarrilli; Giuseppe Castaldo; Aurora Daniele
Journal:  Int J Environ Res Public Health       Date:  2021-04-28       Impact factor: 3.390

Review 7.  Role of myokines and osteokines in cancer cachexia.

Authors:  Fabrizio Pin; Lynda F Bonewald; Andrea Bonetto
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-25

8.  The facts of the matter: What is a hormone?

Authors:  Gerard Karsenty
Journal:  PLoS Genet       Date:  2020-06-26       Impact factor: 5.917

Review 9.  The Role of Bone in Muscle Wasting.

Authors:  Gordon L Klein
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

Review 10.  Functions of Osteocalcin in Bone, Pancreas, Testis, and Muscle.

Authors:  Toshihisa Komori
Journal:  Int J Mol Sci       Date:  2020-10-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.